Biodexa Pharmaceticals Cash Flow-to-Debt Ratio
Biodexa Pharmaceticals cash flow-to-debt ratio. Biodexa Pharmaceticals (BDRX) has a Cash Flow-to-Debt Ratio of -0.34x as of December 2025, meaning its operating cash flow of $-2.33 Million could theoretically repay 0% of its total liabilities ($6.76 Million) in one year. See Biodexa Pharmaceticals (BDRX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biodexa Pharmaceticals (2012–2025)
Cash flow-to-debt ratio of Biodexa Pharmaceticals from 2012 to 2025. Historical debt coverage capacity for Biodexa Pharmaceticals across 14 annual periods. Also explore BDRX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Biodexa Pharmaceticals Cash Flow-to-Debt Ratio by Year (2012–2025)
Biodexa Pharmaceticals cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Biodexa Pharmaceticals. For the full cash flow conversion analysis, see Biodexa Pharmaceticals (BDRX) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.80x | $-5.39 Million | $6.76 Million | ▲ +58.0% |
| 2024 | -1.90x | $-12.26 Million | $6.46 Million | ▼ -63.1% |
| 2023 | -1.16x | $-6.83 Million | $5.86 Million | ▲ +61.0% |
| 2022 | -2.98x | $-7.05 Million | $2.36 Million | ▼ -22.2% |
| 2021 | -2.44x | $-6.01 Million | $2.46 Million | ▲ +18.6% |
| 2020 | -3.00x | $-9.30 Million | $3.10 Million | ▼ -424.4% |
| 2019 | -0.57x | $-6.49 Million | $11.34 Million | ▲ +85.0% |
| 2018 | -3.82x | $-13.45 Million | $3.52 Million | ▼ -329.2% |
| 2017 | -0.89x | $-12.95 Million | $14.55 Million | ▲ +25.4% |
| 2016 | -1.19x | $-13.09 Million | $10.96 Million | ▼ -64.8% |
| 2015 | -0.72x | $-12.42 Million | $17.15 Million | ▲ +38.0% |
| 2014 | -1.17x | $-5.46 Million | $4.67 Million | ▼ -16.1% |
| 2013 | -1.00x | $-4.44 Million | $4.41 Million | ▼ -271.4% |
| 2012 | -0.27x | $-3.22 Million | $11.89 Million | — |